Candidate cancer vaccines: Oncogenic mutations in RAS create HLA-A2.1 binding peptides

被引：0
|
作者：
Smith, MC
Pendleton, CD
Kelley, MJ
Carbone, DP
Berzofsky, JA
机构：
[1] NCI,METAB BRANCH,MOLEC IMMUNOGENET & VACCINE RES SECT,BETHESDA,MD 20892
[2] NCI,NAVY MED ONCOL BRANCH,BETHESDA,MD 20892
[3] UNIV TEXAS,SW MED CTR,DALLAS,TX 75235
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1996年 / 44卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A247 / A247
页数：1
相关论文
共 50 条
  • [41] Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations
    Blaj, Cristina
    Schmidt, Eva Marina
    Lamprecht, Sebastian
    Hermeking, Heiko
    Jung, Andreas
    Kirchner, Thomas
    Horst, David
    [J]. CANCER RESEARCH, 2017, 77 (07) : 1763 - 1774
  • [42] Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity
    Fritah, Hajer
    Graciotti, Michele
    Chiang, Cheryl Lai-Lai
    Huguenin-Bergenat, Anne-Laure
    Petremand, Remy
    Ahmed, Ritaparna
    Guillaume, Philippe
    Schmidt, Julien
    Stevenson, Brian J.
    Gfeller, David
    Harari, Alexandre
    Kandalaft, Lana E.
    [J]. ISCIENCE, 2023, 26 (04)
  • [43] Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-1 envelope protein to human cytotoxic T lymphocytes
    AlexanderMiller, MA
    Parker, KC
    Tsukui, T
    Pendleton, CD
    Coligan, JE
    Berzofsky, JA
    [J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) : 641 - 649
  • [44] PRESENTATION OF 3 DIFFERENT VIRAL PEPTIDES, HTLV-1 TAX, HCMV GB, AND INFLUENZA-VIRUS M1, IS DETERMINED BY COMMON STRUCTURAL FEATURES OF THE HLA-A2.1 MOLECULE
    UTZ, U
    KOENIG, S
    COLIGAN, JE
    BIDDISON, WE
    [J]. JOURNAL OF IMMUNOLOGY, 1992, 149 (01): : 214 - 221
  • [45] A minigene platform to validate novel immunogenic peptides arising from somatic mutations as therapeutic cancer vaccines
    Shi, Xiaoshan
    Kode, Vasumathi
    Lee, Kayla
    Chaudhuri, Amit
    Chakraborty, Papia
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [46] Protective CD8+ T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/Kb transgenic mice
    Ma, Ying
    Tang, Kang
    Zhang, Yusi
    Zhang, Chunmei
    Cheng, Linfeng
    Zhang, Fanglin
    Zhuang, Ran
    Jin, Boquan
    Zhang, Yun
    [J]. VIROLOGY JOURNAL, 2020, 17 (01)
  • [47] Protective CD8+ T-cell response against Hantaan virus infection induced by immunization with designed linear multi-epitope peptides in HLA-A2.1/Kb transgenic mice
    Ying Ma
    Kang Tang
    Yusi Zhang
    Chunmei Zhang
    Linfeng Cheng
    Fanglin Zhang
    Ran Zhuang
    Boquan Jin
    Yun Zhang
    [J]. Virology Journal, 17
  • [48] Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site
    Mazhab-Jafari, Mohammad T.
    Marshall, Christopher B.
    Smith, Matthew J.
    Gasmi-Seabrook, Genevieve M. C.
    Stathopulos, Peter B.
    Inagaki, Fuyuhiko
    Kay, Lewis E.
    Neel, Benjamin G.
    Ikura, Mitsuhiko
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (21) : 6625 - 6630
  • [49] The K-ras let-7 miRNA binding site variant and K-ras mutations in colon cancer
    Dalay, Nejat
    Yalniz, Zubeyde
    Gurbuz, Orkun
    [J]. MOLECULAR CANCER RESEARCH, 2014, 12
  • [50] CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF
    CERNY, A
    MCHUTCHISON, JG
    PASQUINELLI, C
    BROWN, ME
    BROTHERS, MA
    GRABSCHEID, B
    FOWLER, P
    HOUGHTON, M
    CHISARI, FV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02): : 521 - 530
12345